Tue, Nov 03, 2026 - Page 29
26428 indexed SquawkNews stories from this UTC day. Showing 3361-3480.
L
First Guaranty Bancshares files Form 8-K
First Guaranty Bancshares filed a Form 8-K on November 3.
EQUITY | Nov 03, 2026, 09:34 PM UTC
L
Dave & Buster’s Form 4 Filed by Kevin M. Sheehan
A Form 4 for Dave & Buster’s was filed November 3; the filing date references November 2.
EQUITY | Nov 03, 2026, 09:34 PM UTC
L
LKQ Form 4 Filed for Michael Scott Powell
A Form 4 for LKQ Corp. was filed by Michael Scott Powell for Nov. 2.
EQUITY | Nov 03, 2026, 09:34 PM UTC
M
RxSight Q3 Revenue Falls Amid Competitive Pressures
EQUITY | Nov 03, 2026, 09:34 PM UTC
M
Spyre Therapeutics Q3 earnings snapshot
EQUITY | Nov 03, 2026, 09:34 PM UTC
L
Oriental Culture Holding Files Form 6-K
Oriental Culture Holding filed a Form 6-K on November 3.
EQUITY | Nov 03, 2026, 09:34 PM UTC
L
Starfighters Space files DEF 14A for Dec. 17
Starfighters Space filed a DEF 14A on Nov. 3; the headline gives Dec. 17.
EQUITY | Nov 03, 2026, 09:34 PM UTC
L
Loar Holdings Form 4 Filed by Riva Capital Partners IV
A Form 4 for Loar Holdings, filed by Riva Capital Partners IV, covers Nov. 2. The filing date shown is Nov. 3.
EQUITY | Nov 03, 2026, 09:34 PM UTC
L
Everus Construction Group reports 3Q EPS of $1.79
EARNINGS | Nov 03, 2026, 09:34 PM UTC
L
First BanCorp Form 4 Filed for Oct. 30 by Felix Villamil
A Form 4 for First BanCorp covering Oct. 30 was filed Nov. 3.
EQUITY | Nov 03, 2026, 09:34 PM UTC
L
NextEra Energy files Form 425 regarding Dominion Energy
NextEra Energy filed a Form 425 concerning Dominion Energy. The filing date shown is November 3, 20.
EQUITY | Nov 03, 2026, 09:34 PM UTC
L
Matinas BioPharma Files Form 8-K
Matinas BioPharma filed a Form 8-K on November 3.
EQUITY | Nov 03, 2026, 09:34 PM UTC
L
Mayville Engineering files Form 8-K
Mayville Engineering filed a Form 8-K on November 3.
EQUITY | Nov 03, 2026, 09:34 PM UTC
M
Jackson Financial Q3 Adjusted Operating Earnings Rise to $517 Million
Jackson Financial reported Q3 2026 adjusted operating earnings of $517 million, or $7.55 per diluted share, versus $433 million, or $6.16, a year earlier. Net income was $847 million versus $65 million, including a $337
EQUITY | Nov 03, 2026, 09:34 PM UTC
L
First Tracks Biotherapeutics to Participate in Five Investor Conferences
First Tracks Biotherapeutics announced it will participate in five investor conferences.
EQUITY | Nov 03, 2026, 09:34 PM UTC
M
JELD-WEN Reports Third-Quarter 2026 Results
JELD-WEN announced results for the three and nine months ended September 26, 2026, with comparisons to the same periods a year earlier.
EQUITY | Nov 03, 2026, 09:34 PM UTC
L
Itaú Unibanco reports Q3 consolidated loan book in reais
EQUITY | Nov 03, 2026, 09:34 PM UTC
L
Summit Hotel Properties Reports Q3 Hotel EBITDA Margin of 32.6%
EARNINGS | Nov 03, 2026, 09:34 PM UTC
L
Limbach Holdings Q3 operating expenses were $38.777 million
EARNINGS | Nov 03, 2026, 09:34 PM UTC
L
NBT Bancorp files Form 8-K
NBT Bancorp filed a Form 8-K on November 3.
EQUITY | Nov 03, 2026, 09:34 PM UTC
M
Everus Construction Group Q3 Revenue Reaches USD 1,380 Million
Q3 revenue was USD 1,380 million, compared with an IBES estimate of USD 1,189 million.
EQUITY | Nov 03, 2026, 09:34 PM UTC
M
GeoPark Reports Q3 Revenue of USD 116.2 Million
EQUITY | Nov 03, 2026, 09:34 PM UTC
L
Silynxcom Form 4 Filed for October 29
A Form 4 for Silynxcom was filed by Nir Klein. The supplied filing date is November 3.
EQUITY | Nov 03, 2026, 09:34 PM UTC
L
Canadian Imperial Bank files Form 424B2
EQUITY | Nov 03, 2026, 09:34 PM UTC
L
Kaiser Aluminum Form 3 Filed by Stephan Louis Fred
A Form 3 for Kaiser Aluminum was filed on November 3, covering November 1.
EQUITY | Nov 03, 2026, 09:34 PM UTC
M
Booking Holdings Reports Third-Quarter EPS of $3.61
EARNINGS | Nov 03, 2026, 09:34 PM UTC
L
Bristow Group files Form 8-K
Bristow Group filed a Form 8-K on November 3.
EQUITY | Nov 03, 2026, 09:34 PM UTC
L
Roblox insider files Form 144
Gregory Baszucki filed a Form 144 for Roblox Corp.
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
BioStem Technologies Form 4 Filed by Barry Hassett
A Form 4 for BioStem Technologies was filed on November 3.
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
Silynxcom Files Form 4 for October 29
Silynxcom filed a Form 4 for October 29. The filing was made by Gal Nir Klein.
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
Freshworks files Form 10-Q for quarter ended Sept. 30
EQUITY | Nov 03, 2026, 09:33 PM UTC
M
Hackett Group reports third-quarter revenue of $69.8M
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
Horace Mann Filing Exhibit Defines Financial and Operating Measures
The SEC filing exhibit defines management’s financial and operating measures, including core earnings, adjusted book value per share, investment yield and insurance operating ratios. It contains no period-specific earnin
EQUITY | Nov 03, 2026, 09:33 PM UTC
M
Modine fiscal Q2 earnings snapshot
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
JELD-WEN reports third-quarter adjusted EPS
EARNINGS | Nov 03, 2026, 09:33 PM UTC
M
Jack Henry & Associates Reports 1Q Revenue of $701.5M
EARNINGS | Nov 03, 2026, 09:33 PM UTC
M
GeoPark Reports Q3 Adjusted EBITDA of $45.8 Million
EARNINGS | Nov 03, 2026, 09:33 PM UTC
M
Chilean Cobalt Options to Acquire Chile Mining Concessions for $27.5 Million
The company will pay in scheduled installments, and the sellers are entitled to a 1.5% royalty. It also amended its NeoRe Project earn-in and option agreement, extending the decision deadline.
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
Xilio Therapeutics to Present at Stifel Healthcare Conference
Xilio Therapeutics said it will present at the Stifel 2026 Healthcare Conference.
EQUITY | Nov 03, 2026, 09:33 PM UTC
M
Sands China Completes $1 Billion Notes Offering
The Las Vegas Sands subsidiary issued $700 million of 6.400% notes due 2032 and $300 million of 6.700% notes due 2033.
EQUITY | Nov 03, 2026, 09:33 PM UTC
M
JELD-WEN Sees FY Revenue of $3.1B-$3.2B
EARNINGS | Nov 03, 2026, 09:33 PM UTC
M
JELD-WEN reports third-quarter loss of $17.2 million
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
Blue Acquisition Secures Up to $50,000 Interest-Free Note From Director
Blue Acquisition entered into an unsecured promissory note with director Dario Dino Ferrari to fund working capital. The note is interest-free and may be drawn before it becomes due upon the earlier of the company’s init
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
XPO Insider Form 4 Filed for Nov. 2
A Form 4 for XPO, Inc., filed by David J. Bates, covers Nov. 2. The filing date is November 3.
EQUITY | Nov 03, 2026, 09:33 PM UTC
M
JELD-WEN Reports Third-Quarter Loss per Share
EQUITY | Nov 03, 2026, 09:33 PM UTC
M
Super Micro Q1 Earnings Snapshot
EQUITY | Nov 03, 2026, 09:33 PM UTC
M
Seadrill Reports Q3 Net Loss After Legal Provision Impact
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
Silynxcom Form 4 Filed for Oct. 29
A Form 4 associated with Ron Klein was filed for Oct. 29.
EQUITY | Nov 03, 2026, 09:33 PM UTC
M
Intrepid Potash Increases Trio Production Guidance by 10,000 Tons
EARNINGS | Nov 03, 2026, 09:33 PM UTC
L
Mingteng International Files Form 6-K/A
Mingteng International filed a Form 6-K/A on November 3.
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
Bristol Myers Squibb Form 4 Filed for Nov. 1
A Form 4 for Bristol Myers Squibb was filed by Christopher S. Boerner on November 3.
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
Teamshares Management to Present at Roth Technology Conference
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
Verra Mobility Announces Inducement Grant
Verra Mobility announced an inducement grant under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
Goldman Sachs Note Flags Risks in Corporate Bond Yield Gap Above 9%
Goldman Sachs' Bobby Molavi said the gap between Triple-C and Single-B corporate debt yields has exceeded 9%. He cited similar spreads in 2000 and 2015 that were followed by significant market declines.
RATES | Nov 03, 2026, 09:33 PM UTC
M
GXO Q3 Adjusted EBITDA Comes in at $251 Million
GXO Logistics reported Q3 adjusted EBITDA of $251 million, versus the IBES estimate of $252.6 million.
EARNINGS | Nov 03, 2026, 09:33 PM UTC
L
OpenWorld Schedule 13D/A Filed by Gerard Hernandez
A Schedule 13D/A for OpenWorld was filed by Gerard Albert Palana Hernandez.
EQUITY | Nov 03, 2026, 09:33 PM UTC
M
Arista Networks Reports Third-Quarter Adjusted EPS of $1.20
EARNINGS | Nov 03, 2026, 09:33 PM UTC
M
Amgen Reports Q3 2026 Revenue of $10.4 Billion, Up 8%
Amgen reported diluted GAAP EPS of $7.08 and non-GAAP diluted EPS of $6.45, versus $5.64 a year earlier. It maintained its full-year 2026 revenue and EPS guidance ranges.
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
Limbach Holdings Reports Q3 Net Income of USD 9.45 Million
EARNINGS | Nov 03, 2026, 09:33 PM UTC
L
Equinix Asia Financing Files Form FWP
Equinix Asia Financing Corp. Pte. Ltd. filed a Form FWP.
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
NCLA Seeks Court Order to End Washington Crab-Boat Surveillance
The New Civil Liberties Alliance has filed a motion seeking to end the Washington Department of Fish and Wildlife’s 24-hour surveillance of crab boats.
REGULATION | Nov 03, 2026, 09:33 PM UTC
L
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
Kevin Sayer Joins Guardant Health Board
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
X4 Pharmaceuticals to Attend Three Conferences in November 2026
X4 Pharmaceuticals plans to participate in conferences hosted by Guggenheim, Stifel and Jefferies in November 2026.
EQUITY | Nov 03, 2026, 09:33 PM UTC
M
Melcor Developments Reports Q3 FFO of C$17.086 Million
EARNINGS | Nov 03, 2026, 09:33 PM UTC
L
AdaptHealth files Form 10-Q for quarter ended Sept. 30
AdaptHealth Corp. filed a Form 10-Q for the period ended Sept. 30.
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
Hackett Group files Form 8-K
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
GATX Form 144 Filed by Robert C. Lyons
A Form 144 for GATX Corp. was filed by Robert C. Lyons.
EQUITY | Nov 03, 2026, 09:33 PM UTC
L
Goldman Sachs Files Form 424B2
Goldman Sachs filed a Form 424B2 on November 3.
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
Viking Therapeutics to Participate in Investor Conferences
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
Invesco Unit Trusts File Form S-6
Invesco Unit Trusts filed a Form S-6.
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
Postal Realty Trust Q3 Rental Income Rises 25% on Acquisitions
EARNINGS | Nov 03, 2026, 09:32 PM UTC
L
BlueLinx Q3 Sales Rise on Disdero Lumber Growth and Higher Pricing
EARNINGS | Nov 03, 2026, 09:32 PM UTC
L
Tronox declares fourth-quarter 2026 dividend
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
Dauch Corporation Announces Employee Inducement Award
Dauch Corporation announced an employee inducement award under NYSE Rule 303A.08.
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
Bank of Montreal files Form 424B2
EQUITY | Nov 03, 2026, 09:32 PM UTC
M
South Plains Financial Reports Third-Quarter Revenue of $65.3 Million, EPS of $1.06
Third-quarter 2026 revenue rose 20.5% year over year to $65.3 million, net income increased 27.3% to $20.8 million, and diluted EPS rose 10.4% to $1.06. Growth reflected higher net interest and noninterest income.
EQUITY | Nov 03, 2026, 09:32 PM UTC
M
AdaptHealth Reports Q3 2026 Revenue of $745.65 Million, Net Loss
Revenue rose 10.9% year over year to $745.65 million. Net loss attributable to the company was $153.99 million, versus income of $24.51 million a year earlier; diluted loss per share was $1.13, compared with income of $0
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
Hormel Foods Announces Fourth Quarter Earnings Call
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
Vanda Pharmaceuticals to Participate in November Investor Conferences
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
BofA Finance LLC files Form 424B2
BofA Finance LLC filed a Form 424B2. The filing date is shown as November 3, 20.
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
Signal Strike Capital files Form D/A
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
UDR Reports Results for Quarter Ended September 30
LSEG data identifies UDR’s quarterly results for the period ended September 30; no figures are provided in the supplied text.
EARNINGS | Nov 03, 2026, 09:32 PM UTC
M
Safehold Q3 Revenue Beats Analyst Expectations
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
Solstice Advanced Materials Declares $0.075 Per-Share Dividend
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
Verra Mobility Announces Inducement Grant
Verra Mobility announced an inducement grant under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Nov 03, 2026, 09:32 PM UTC
M
Bristow Group Affirms 2026 Adjusted EBITDA Midpoint
EARNINGS | Nov 03, 2026, 09:32 PM UTC
L
X4 Pharmaceuticals to Participate in Three Conferences in November 2026
X4 Pharmaceuticals plans to participate in conferences hosted by Guggenheim, Stifel and Jefferies in November 2026.
EQUITY | Nov 03, 2026, 09:32 PM UTC
M
Navitas Semiconductor Reports $13.99 Million in Third-Quarter Revenue
Revenue rose 38.4% from a year earlier, while the net loss widened to $37.11 million and diluted loss per share was $0.14. The company attributed growth primarily to U.S. data-center demand.
EQUITY | Nov 03, 2026, 09:32 PM UTC
M
Voyager Technologies Reports Third-Quarter Revenue of $88.72 Million
Third-quarter 2026 revenue rose 124.1% year over year to $88.72 million. Net loss available to common shareholders widened to $55.68 million, and diluted loss per share was $0.91.
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
DiamondRock Hospitality Q3 Net Income and Adjusted FFO Rise
EARNINGS | Nov 03, 2026, 09:32 PM UTC
M
Oriental Culture Holding Reports $0.9M First-Half Net Income
The company reported unaudited first-half 2026 net income of approximately $0.9 million, versus a $3.8 million loss in first-half 2025. Revenue rose to $1.0 million from $141,400.
EARNINGS | Nov 03, 2026, 09:32 PM UTC
M
Accel Entertainment Reports Record Third-Quarter Revenue of $364 Million
EQUITY | Nov 03, 2026, 09:32 PM UTC
M
Independence Realty Trust Reports Third-Quarter Revenue of $172.1 Million
Revenue rose 3% year over year to $172.1 million. Net income attributable to common shares was $25.1 million, compared with $6.9 million a year earlier, including a $26.5 million gain on a property sale.
EQUITY | Nov 03, 2026, 09:32 PM UTC
M
Navigator Holdings Q3 2026 Net Income More Than Doubles
Navigator Holdings reported third-quarter 2026 net income more than double the year-earlier figure. Revenue rose.
EARNINGS | Nov 03, 2026, 09:32 PM UTC
M
Pacific Health Care Organization Reports Nine-Month Revenue of $1.51M
For the nine months, revenue fell 4.7% year over year to $1.51 million, while net income rose 50% to $334.61K and diluted EPS increased to $0.03 from $0.02.
EARNINGS | Nov 03, 2026, 09:32 PM UTC
L
Hackett Group Q3 Adjusted EPS Beats Estimates
EARNINGS | Nov 03, 2026, 09:32 PM UTC
M
Sanofi Discontinues Autoimmune Drug Program, Nurix Says
Nurix said Sanofi ended development of an experimental treatment for autoimmune and inflammatory diseases, eliminating potential future milestone payments and royalties tied to the program.
EQUITY | Nov 03, 2026, 09:32 PM UTC
M
DXP Enterprises Announces Acquisition of MDS of Michigan
MNA | Nov 03, 2026, 09:32 PM UTC
L
Kevin Sayer Joins Guardant Health Board
EQUITY | Nov 03, 2026, 09:32 PM UTC
M
Melcor Developments Announces Third-Quarter Results and $0.15 Quarterly Dividend
Melcor Developments announced third-quarter results and declared a quarterly dividend of $0.15 per share.
EQUITY | Nov 03, 2026, 09:32 PM UTC
M
GXO Logistics Q3 Adjusted EPS Reaches $0.89, Above Estimate
GXO reported Q3 EPS of $0.56; adjusted EPS was $0.89 versus the IBES estimate of $0.86.
EARNINGS | Nov 03, 2026, 09:32 PM UTC
M
Intrepid Potash Reports Q3 Sales of USD 51 Million
Reuters also reports Q3 adjusted EBITDA of USD 11.7 million.
EARNINGS | Nov 03, 2026, 09:32 PM UTC
L
TPG Mortgage Investment Form 4 Filed by Mitchell M. Christian
A Form 4 for TPG Mortgage Investment was filed by Mitchell M. Christian. The filing date is shown as November 3, with the year truncated in the source.
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
Mistral Iberia Real Estate Calls Extraordinary Shareholders’ Meeting
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
VSE Corporation declares quarterly cash dividend
EQUITY | Nov 03, 2026, 09:32 PM UTC
M
XMax Announces Preliminary Third-Quarter 2026 Financial Results
XMax announced selected preliminary, unaudited financial results for the third quarter of 2026.
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
Olema Reports Inducement Grants Under Nasdaq Listing Rule
Olema Pharmaceuticals reported inducement grants under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Nov 03, 2026, 09:32 PM UTC
M
Itaú Unibanco Q3 Net Interest Income Reaches 34.6 Billion Reais
EARNINGS | Nov 03, 2026, 09:32 PM UTC
L
Teamshares Management to Present at Roth Technology Conference
EQUITY | Nov 03, 2026, 09:32 PM UTC
M
GeoPark Reports Third-Quarter Revenue of $116.20
EQUITY | Nov 03, 2026, 09:32 PM UTC
M
Alight Reports Third-Quarter 2026 Revenue of $500 Million
Revenue fell 6.2% year over year to $500 million. Alight recorded a $51 million net loss attributable to the company, versus a $1.067 billion loss a year earlier; EPS was ($1.93).
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
Xilio Therapeutics to Present at Stifel Healthcare Conference
Xilio Therapeutics plans to present at the Stifel 2026 Healthcare Conference.
EQUITY | Nov 03, 2026, 09:32 PM UTC
M
WSFS Financial Reports Third-Quarter Net Income of $59.1 Million
WSFS Financial said net income rose 28.2% year over year to $59.1 million. Net interest income increased 6.8% to $196.6 million, and diluted EPS rose to $1.75 from $1.37.
EARNINGS | Nov 03, 2026, 09:32 PM UTC
L
Bristow Group Reports 3Q Net Income of $27.7 Million
EARNINGS | Nov 03, 2026, 09:32 PM UTC
L
Travere Therapeutics to Participate in Upcoming Investor Conferences
Travere Therapeutics announced it will participate in upcoming investor conferences.
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
Sierra Bancorp Form 144 Filed by Lynda Scearcy
A Form 144 for Sierra Bancorp was filed by Lynda Scearcy. The filing date is listed as November 3, 20.
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
Olema reports inducement grants under Nasdaq listing rule
Olema Pharmaceuticals reports inducement grants under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
Itaú Unibanco Q3 90-Day Default Ratio at 2%
EQUITY | Nov 03, 2026, 09:32 PM UTC
L
X4 Pharmaceuticals to Attend Three Investor Conferences in November
X4 Pharmaceuticals said management will participate in several investment conferences in November 2026.
EQUITY | Nov 03, 2026, 09:32 PM UTC